Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

  1. Bandres, E.
  2. Rodriguez, J.
  3. Hernandez, A.
  4. Bitarte, N.
  5. Ramirez, N.
  6. Diaz-Gonzalez, J. A.
  7. Chopitea, A.
  8. Ponz, M.
  9. Zarate, R. N.
  10. Garcia-Foncillas, J.
Revista:
EJC SUPPLEMENTS

ISSN: 1359-6349

Ano de publicación: 2009

Volume: 7

Número: 2

Páxinas: 113-113

Congreso: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Tipo: Achega congreso

DOI: 10.1016/S1359-6349(09)70388-X GOOGLE SCHOLAR
Fonte de datos: WoS